Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020

Rhea-AI Summary

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) announced that it will release its financial results for Q2 2020 on July 30, 2020, after market close. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and recent company developments. Investors can listen by dialing 877-407-3036 or via a live webcast on the company’s website. A replay will be available for two weeks. Ekso Bionics is a leader in exoskeleton technology, focusing on medical and industrial applications, and aims to enhance human mobility and endurance.

Positive

• Upcoming financial results release on July 30, 2020, may provide insights into growth.
• Conference call scheduled to discuss business developments, signaling transparency.

Negative

• None.

RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2020 after the close of trading on Thursday, July 30, 2020. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers. A live webcast of the event will be available in the “Investors” section of the company’s website at www.eksobionics.com, or by clicking here.

A replay of the call will be available for two weeks by dialing 877-660-6853 for domestic callers or 201-612-7415 for international callers and using Conference ID: 13706452. The webcast will also be available on the company’s website for one month following the completion of the call.

About Ekso Bionics^®

Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:
David Carey
212-867-1768
investors@eksobionics.com

Media Contact:
Carrie Yamond Mas
917-371-2320
cmas@eksobionics.com

FAQ

When will Ekso Bionics release its Q2 2020 financial results?

Ekso Bionics will release its Q2 2020 financial results on July 30, 2020.

What time is the Ekso Bionics conference call?

The Ekso Bionics conference call will begin at 1:30 p.m. PT / 4:30 p.m. ET on July 30, 2020.

How can I listen to the Ekso Bionics conference call?

You can listen to the Ekso Bionics conference call by dialing 877-407-3036 for domestic calls or via a live webcast on their website.

Will there be a replay of the Ekso Bionics conference call?

Yes, a replay of the call will be available for two weeks after the event.

What is the focus of Ekso Bionics?

Ekso Bionics focuses on developing exoskeleton technology for medical and industrial applications, enhancing mobility and endurance.